Literature DB >> 16765602

Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice.

M Oksman1, H Iivonen, E Hogyes, Z Amtul, B Penke, I Leenders, L Broersen, D Lütjohann, T Hartmann, H Tanila.   

Abstract

The present study assessed the influence of dietary lipids on accumulation of amyloid beta-peptide (Abeta) in the brain. Seven experimental diets with varying n-6/n-3-ratio, saturated and polyunsaturated fatty acid and cholesterol contents were fed to transgenic APPswe/PS1dE9 mice for 3-4 months beginning at a young adult age (6 months). Hippocampal Abeta levels were determined with ELISA and plaque load by using immunocytochemistry. A typical Western diet with 40% saturated fatty acids and 1% of cholesterol increased, while diets supplemented with docosahexaenoic acid (DHA) decreased Abeta levels compared to regular (soy oil based) diet. DHA diet also decreased the number of activated microglia in hippocampus and increased exploratory activity of transgenic mice, but did not improve their spatial learning in the water maze. The favorable effect of DHA on Abeta production was verified in two different cell lines. Regulation of dietary lipid intake may offer a new tool to reduce the risk of Alzheimer's disease at the population level.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16765602     DOI: 10.1016/j.nbd.2006.04.013

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  89 in total

Review 1.  Dietary fatty acids and the aging brain.

Authors:  Greg M Cole; Qiu-Lan Ma; Sally A Frautschy
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

2.  Palmitate-activated astrocytes via serine palmitoyltransferase increase BACE1 in primary neurons by sphingomyelinases.

Authors:  Li Liu; Rebecca Martin; Christina Chan
Journal:  Neurobiol Aging       Date:  2012-06-23       Impact factor: 4.673

3.  Characterization of AD-like phenotype in aged APPSwe/PS1dE9 mice.

Authors:  Huang Huang; Sipei Nie; Min Cao; Charles Marshall; Junying Gao; Na Xiao; Gang Hu; Ming Xiao
Journal:  Age (Dordr)       Date:  2016-07-21

4.  Neurometabolic roles of ApoE and Ldl-R in mouse brain.

Authors:  Jieun Lee; Joseph Choi; G William Wong; Michael J Wolfgang
Journal:  J Bioenerg Biomembr       Date:  2015-12-21       Impact factor: 2.945

5.  Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.

Authors:  Nicolas G Bazan; Miguel F Molina; William C Gordon
Journal:  Annu Rev Nutr       Date:  2011-08-21       Impact factor: 11.848

6.  Structural insight into the differential effects of omega-3 and omega-6 fatty acids on the production of Abeta peptides and amyloid plaques.

Authors:  Zareen Amtul; Markus Uhrig; Richard F Rozmahel; Konrad Beyreuther
Journal:  J Biol Chem       Date:  2010-10-22       Impact factor: 5.157

Review 7.  Nutritional Lipidomics in Alzheimer's Disease.

Authors:  Efstathia Kalli
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

8.  Omega-3 fatty acids moderate effects of physical activity on cognitive function.

Authors:  Regina L Leckie; Stephen B Manuck; Neha Bhattacharjee; Matthew F Muldoon; Janine M Flory; Kirk I Erickson
Journal:  Neuropsychologia       Date:  2014-05-09       Impact factor: 3.139

Review 9.  Cellular membrane fluidity in amyloid precursor protein processing.

Authors:  Xiaoguang Yang; Grace Y Sun; Gunter P Eckert; James C-M Lee
Journal:  Mol Neurobiol       Date:  2014-02-20       Impact factor: 5.590

10.  Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.

Authors:  Qiu-Lan Ma; Fusheng Yang; Emily R Rosario; Oliver J Ubeda; Walter Beech; Dana J Gant; Ping Ping Chen; Beverly Hudspeth; Cory Chen; Yongle Zhao; Harry V Vinters; Sally A Frautschy; Greg M Cole
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.